| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACLY
|
ATP citrate lyase
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AIRE
|
autoimmune regulator
|
|
AKAP5
|
A kinase (PRKA) anchor protein 5
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARRB2
|
arrestin, beta 2
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ATF1
|
activating transcription factor 1
|
|
ATF4
|
activating transcription factor 4
|
|
ATF6
|
activating transcription factor 6
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AZU1
|
azurocidin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BOK
|
BCL2-related ovarian killer
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CHD1
|
chromodomain helicase DNA binding protein 1
|
|
CHIA
|
chitinase, acidic
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLDN4
|
claudin 4
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
DEDD
|
death effector domain containing
|
|
DEDD2
|
death effector domain containing 2
|
|
DEFB4A
|
defensin, beta 4A
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EP300
|
E1A binding protein p300
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHL5
|
four and a half LIM domains 5
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FTO
|
fat mass and obesity associated
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GBA
|
glucosidase, beta, acid
|
|
GH1
|
growth hormone 1
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HMOX2
|
heme oxygenase 2
|
|
HOXB9
|
homeobox B9
|
|
HRH4
|
histamine receptor H4
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL19
|
interleukin 19
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL20
|
interleukin 20
|
|
IL24
|
interleukin 24
|
|
IL31
|
interleukin 31
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KHK
|
ketohexokinase (fructokinase)
|
|
LAMA5
|
laminin, alpha 5
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LTA
|
lymphotoxin alpha
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LYZ
|
lysozyme
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED25
|
mediator complex subunit 25
|
|
MIEF1
|
mitochondrial elongation factor 1
|
|
MIEF2
|
mitochondrial elongation factor 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR18A
|
microRNA 18a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR219A2
|
microRNA 219a-2
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR31
|
microRNA 31
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSX2
|
msh homeobox 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NPPC
|
natriuretic peptide C
|
|
NPY
|
neuropeptide Y
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAOX
|
polyamine oxidase (exo-N4-amino)
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PGF
|
placental growth factor
|
|
PHB
|
prohibitin
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POMC
|
proopiomelanocortin
|
|
PPAPDC2
|
phosphatidic acid phosphatase type 2 domain containing 2
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRLR
|
prolactin receptor
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROX1
|
prospero homeobox 1
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAB7B
|
RAB7B, member RAS oncogene family
|
|
RAB9A
|
RAB9A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RETN
|
resistin
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SDC4
|
syndecan 4
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELE
|
selectin E
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SH3RF1
|
SH3 domain containing ring finger 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGLEC11
|
sialic acid binding Ig-like lectin 11
|
|
SIRT1
|
sirtuin 1
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD3
|
SMAD family member 3
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMOX
|
spermine oxidase
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STAB2
|
stabilin 2
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TACR3
|
tachykinin receptor 3
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCP1
|
t-complex 1
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIB1
|
tribbles pseudokinase 1
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPO2
|
translocator protein 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UCN
|
urocortin
|
|
UCN2
|
urocortin 2
|
|
UCN3
|
urocortin 3
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XBP1
|
X-box binding protein 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YY1AP1
|
YY1 associated protein 1
|
|
ZHX1
|
zinc fingers and homeoboxes 1
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
|
ZHX3
|
zinc fingers and homeoboxes 3
|
